Bayesian Capital Management, LP - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 158 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 2.50 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bayesian Capital Management, LP ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$146,832
-78.8%
13,800
-75.0%
0.02%
-84.5%
Q1 2022$693,000
+225.4%
55,100
+161.1%
0.10%
+123.9%
Q1 2020$213,000
+36.5%
21,100
+80.3%
0.05%
+70.4%
Q4 2019$156,000
-16.6%
11,700
-18.2%
0.03%
-75.9%
Q2 2016$187,00014,3110.11%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders